Press Release: UPENN and MILabs join forces

Press release: UPENN and MILabs join forces to advance SPECT pre-clinical Imaging

September 1st, 2014

UPENNUniversity of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications. The system is installed in the John Morgan Building at the University of Pennsylvania Perelman School of Medicine. Utilization of the system will be led by Research Associate Professor Scott Metzler, PhD. of the Physics and Instrumentation Group of the Department of Radiology. Dr. Metzler’s work focuses on high performance SPECT instrumentation and image reconstruction including the development of adaptive SPECT. Much of this new development work will be a collaboration between the University of Pennsylvania, MILabs and Delft University of Technology (PI: Prof. Freek Beekman, Ph.D.).  In addition the Department of Radiology at UPENN will use the U-SPECT+ in various biomedical applications, such as brain and cardiac research.

MILabs is very excited to have the opportunity to work with such a prestigious institution and team of excellent investigators at the University of Pennsylvania and for the U-SPECT+ system to play such a significant role in supporting the development and advancement of biomedical research.

About the University of Pennsylvania

UPENN is one of the nation’s premier research institutions with more than $700M in annual R&D expenditures. Within the University of Pennsylvania, the Perelman School of Medicine advances research and academic efforts at UPENN and neighboring scientific communities with 21 research cores offering a complete range of services. UPENN has a long history of development of nuclear medicine instrumentation in both SPECT and PET dating back to pioneering work in the 1970’s.  The Physics and Instrumentation Research Group works to continue this tradition with development of new technology and collaboration between basic science and clinicians to optimize their use for both clinical and pre-clinical imaging applications.

www.pennmedicine.org

About MILabs

MILabs provides high-end preclinical molecular imaging solutions for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as cancer, cardiac and neurodegenerative diseases and diabetes. U-SPECT/CT provides the fastest, most sensitive and highest resolution small-animal SPECT currently available. Recently MILabs introduced VECTor+ and VECTor/CT providing extremely user friendly, fully integrated and simultaneous ultra-high resolution SPECT/PET.

For more information please visit us on: www.milabs.com

Share on social media

Beckman Institute welcomes new ultra-high-performance PET-CT scanner

Beckman Institute at the University of Illinois, Urbana-Champaign Improves Previous Imaging Functionality with Launch of ...
Read More →

Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands – Prof. Harrie Weinans & Dr. Bart van der Wal

  – Spotlight on the Orthopedic Imaging at UMC Utrecht, the Netherlands –  – Prof. ...
Read More →

Press Release: MILABS launches its 7th generation of preclinical imagers at the World Molecular Imaging Conference 2021

Under the new ownership of the Rigaku Group (Tokyo, Japan), MILabs is pushing the value ...
Read More →

Press Release: RIGAKU Acquires Life Science Imaging Equipment Manufacturer MILabs

August 3, 2021 – Houten, the Netherlands Dear readers, We are very excited that MILabs ...
Read More →

Press Release: Confocal PET Causes Spectral PET Breakthrough in Preclinical Imaging

Houten, the Netherlands – March 24, 2021 Using its unique Confocal PET technology, MILabs B.V ...
Read More →

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University

Spotlight on Akiva Mintz, MD, Ph.D. – Columbia University – Bridging the “valley of death” ...
Read More →

Spotlight on Bart Cornelissen, PhD – Department of Oncology, Oxford Institute for Radiation Oncology at University of Oxford

– Targeting Tumors from the inside –   Dr. Bart Cornelissen is Group Leader and ...
Read More →

Spotlight on Prof. Twan Lammers – ExMI-RWTH Aachen

A Pioneering Mind in Nanomedicine and Theranostics Prof. Dr. Dr. Twan Lammers is Head of ...
Read More →

Miltenyi Biotec strengthens its research capabilities for cell analysis and preclinical imaging by acquiring a MILabs’ premium Optical/CT imaging system

  Utrecht and Bergisch Gladbach, September 9, 2020 Miltenyi Biotec B.V. & Co. KG, a ...
Read More →

MILabs announced the co-winners of the 2020 MILabs Image of the Year Award

September 4, 2020, Utrecht, The Netherlands Each year, at the occasion of the Annual Congress ...
Read More →

Bayer AS installs top-of-the-line MILabs VECTor PET/SPECT/CT to advance its targeted alpha therapy programs

August 27, 2020, Oslo-Norway and Utrecht-The Netherlands Bayer AS has installed a state-of-the-art MILabs VECTor ...
Read More →

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam

Spotlight on Prof. Marion de Jong – Erasmus MC Rotterdam On the frontline of fighting ...
Read More →
Scroll to Top